#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16604	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2140	772.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1672	1672	T	948	T	837	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16604	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2140	772.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1406	1406	C	964	C,A	884,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30628	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3535	864.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1665	1665	A	1066	A	957	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30628	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3535	864.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2299	2299	C	964	C,A,T	867,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30628	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3535	864.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2373	2373	A	937	A	849	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30628	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3535	864.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2925	2925	C	939	C,T	861,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2456	folP	855	855	100.0	folP.l15.c30.ctg.1	1467	166.2	1	SNP	p	R229S	1	.	.	685	687	AGC	950	952	AGC	310;307;305	A;G;C	284;279;276	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6340	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3366	188.0	1	SNP	p	S91F	1	.	.	271	273	TTC	552	554	TTC	227;226;231	T;T,C;C	204;204,1;207	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6340	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3366	188.0	1	SNP	p	D95G	1	.	.	283	285	GGC	564	566	GGC	227;227;224	G;G,A;C	203;197,1;198	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6340	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3366	188.0	1	SNP	p	G95N	0	.	.	283	285	GGC	564	566	GGC	227;227;224	G;G,A;C	203;197,1;198	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1900	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1208	156.9	1	SNP	p	G45D	0	.	.	133	135	GGC	402	404	GGC	251;248;249	G;G;C	232;225;227	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1008	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	978	102.8	0	.	n	.	0	A197.	DEL	197	197	A	629	629	A	266	A	238	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5798	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2769	208.3	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1324	1326	GTC	230;231;231	G;T;C	211;212;211	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5798	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2769	208.3	1	SNP	p	D86N	0	.	.	256	258	GAC	430	432	GAC	241;242;241	G;A;C	213;211;214	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5798	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2769	208.3	1	SNP	p	S87R	1	.	.	259	261	CGT	433	435	CGT	242;239;238	C;G;T	219;214;213	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5798	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2769	208.3	1	SNP	p	R87W	0	.	.	259	261	CGT	433	435	CGT	242;239;238	C;G;T	219;214;213	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5798	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2769	208.3	1	SNP	p	R87I	0	.	.	259	261	CGT	433	435	CGT	242;239;238	C;G;T	219;214;213	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5798	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2769	208.3	1	SNP	p	S88P	0	.	.	262	264	TCC	436	438	TCC	238;237;236	T;C;C	212;211;211	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	5244	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2741	190.8	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1349	1351	TGC	252;247;248	T;G;C	224;218;222	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	5244	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2741	190.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1559	1561	GGC	253;253;257	G;G,T;C	221;222,1;225	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	4648	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	194.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1260	1262	GCA	250;249;253	G;C,G;A	220;217,1;225	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4648	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	194.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1263	1265	ATC	255;255;258	A;T;C	223;222;224	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4648	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	194.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1275	1277	GTG	254;256;257	G;T;G	220;224;225	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4648	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	194.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1275	1277	GTG	254;256;257	G;T;G	220;224;225	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4648	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	194.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1779	1781	ACC	246;246;247	A;C;C	221;227;227	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4648	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	194.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1833	1835	GCG	233;233;227	G;C;G	208;187;185	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4648	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	194.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1833	1835	GCG	233;233;227	G;C;G	208;187;185	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4648	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	194.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1956	1958	GGC	225;226;226	G,A;G;C	205,1;206;206	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4648	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	194.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1965	1967	GGC	236;239;237	G;G;C	214;215;212	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4648	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	194.9	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1983	1985	TCG	234;235;234	T,G,C;C;G,C	153,11,1;179;186,3	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6776	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3095	218.5	0	.	p	.	0	E418G	NONSYN	1252	1254	GAG	1614	1616	GGG	257;256;257	G;G;G	226;231;230	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6776	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3095	218.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1623	1625	CCG	250;253;250	C;C;G	219;229;215	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2704	porA	1146	1146	99.56	porA.l6.c4.ctg.1	1774	151.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	548	548	C	189	C	170	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3136	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1493	208.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	395	397	GAA	259;258;253	G;A;A,C	237;235;230,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3136	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1493	208.9	0	.	p	.	0	N134D	NONSYN	400	402	AAT	683	685	GAT	271;267;267	G;A;T,C	241;241;239,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3136	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1493	208.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	806	808	TCA	259;259;261	T;C;A	233;233;237	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3136	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1493	208.9	0	.	p	.	0	A218V	NONSYN	652	654	GCC	935	937	GTC	258;262;262	G,T;T;C,A	239,1;241;241,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3136	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1493	208.9	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1265	1267	GCA	255;254;254	G;C;A	234;235;237	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3136	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1493	208.9	1	SNP	p	G120K	1	.	.	358	360	AAG	641	643	AAG	249;248;253	A;A;G	228;227;232	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3136	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1493	208.9	1	SNP	p	A121D	1	.	.	361	363	GAC	644	646	GAC	256;253;251	G;A;C	233;230;231	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3136	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1493	208.9	1	SNP	p	D121N	0	.	.	361	363	GAC	644	646	GAC	256;253;251	G;A;C	233;230;231	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12040	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4833	248.7	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1951	1953	AAT	273;274;274	A;A;T	249;250;250	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1226	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1026	119.1	1	SNP	p	V57M	1	.	.	169	171	ATG	524	526	ATG	255;254;254	A;T;G	238;235;236	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
